| Description | HCV-IN-31 is a HCV inhibitor with an EC50/EC95 of 15.7 μM. |
| Target activity | HCV replicon:15.7 μM(EC50/EC95) |
| molecular weight | 312.3 |
| Molecular formula | C12H17FN6O3 |
| CAS | 1998705-62-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 50 mg/mL (160.10 mM) |
| References | 1. Jean-Pierre Sommadossi, et al. Beta-D-2'-DEOXY-2'-alpha-FLUORO-2'-beta-C-SUBSTITUTED-2-MODIFIED-N6-SUBSTITUTED PURINE NUCLEOTIDES FOR HCV TREATMENT. US20160257706A1 |